Transjugular intrahepatic portosystemic shunt (TIPS) has been used for more than 20 years to treat some of the complications of portal hypertension. When TIPS was initially proposed, it was claimed that the optimal calibration of the shunt could allow an adequate reduction of portal hypertension, avoiding, at the same time, the occurrence of hepatic encephalopathy (HE), a neurologic syndrome. However, several clinical observations have shown that HE occurred rather frequently after TIPS, and HE has become an important issue to be taken into consideration in TIPS candidates and a problem to be faced after the procedure.
Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt / Riggio, Oliviero; Nardelli, Silvia; Moscucci, Federica; Pasquale, Chiara; Ridola, Lorenzo; Merli, Manuela. - In: CLINICS IN LIVER DISEASE. - ISSN 1089-3261. - STAMPA. - 16:1(2012), pp. 133-146. [10.1016/j.cld.2011.12.008]
Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt
RIGGIO, Oliviero;NARDELLI, SILVIA;MOSCUCCI , FEDERICA;PASQUALE, CHIARA;RIDOLA, LORENZO;MERLI, Manuela
2012
Abstract
Transjugular intrahepatic portosystemic shunt (TIPS) has been used for more than 20 years to treat some of the complications of portal hypertension. When TIPS was initially proposed, it was claimed that the optimal calibration of the shunt could allow an adequate reduction of portal hypertension, avoiding, at the same time, the occurrence of hepatic encephalopathy (HE), a neurologic syndrome. However, several clinical observations have shown that HE occurred rather frequently after TIPS, and HE has become an important issue to be taken into consideration in TIPS candidates and a problem to be faced after the procedure.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
